Home/ Stocks/ TXG

10x Genomics, Inc. Class A Common Stock

TXG XNAS

$52.03 +6.10 (+13.38%) ▲ 15-min delayed

Open

$45.51

High

$52.22

Low

$44.39

Volume

5.43M

Market Cap

$5.79B

About 10x Genomics, Inc. Class A Common Stock

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Sector: LABORATORY ANALYTICAL INSTRUMENTS Employees: 1.2K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$150.84M	$-13,470,000	$-0.10
FY 2025	$642.82M	$-43,544,000	$-0.35
Q3 2025	$149.00M	$-27,472,000	$-0.22
Q2 2025	$172.91M	$34.54M	$0.28

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for TXG yet. Check out our latest market news or earnings calendar.

Get TXG Alerts

Stay ahead with breaking news, price alerts, and expert analysis on 10x Genomics, Inc. Class A Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.